Abstract
Serological diagnoses of human infections with California serogroup viruses are usually made by means of complement fixation or hemagglutination inhibition tests or both. An analysis of antibody titers in sera from 128 humans with California (La Crosse) virus infections indicated that exclusive use of the complement fixation tests would have detected only 50% of the actual seroconversions, whereas hemagglutination inhibition and neutralization tests alone would have been sufficient to make the diagnosis in 79.3% and 84.8% of the cases, respectively. These and other results presented demonstrate that the complement fixation test is not sufficiently useful as a primary tool for diagnosis of La Crosse virus infections. We suggest the use of the hemagglutination inhibition test for preliminary screening of sera from individuals with suspect infections caused by California serogroup viruses. The neutralization test should then be used or confirmation and subtype identification. If hemagglutination inhibition and neutralization titers are high and stable, the complement fixation test should then be used as a last, but specific, resort.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bárdos V., Medek M., Kania V., Hubálek Z. Isolation of Tahyna virus from the blood of sick children. Acta Virol. 1975 Sep;19(5):447–447. [PubMed] [Google Scholar]
- CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
- Calisher C. H., Maness K. S. Arbovirus identification by an agar-gel diffusion technique. Appl Microbiol. 1970 Apr;19(4):557–564. doi: 10.1128/am.19.4.557-564.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fauvel M., Artsob H., Calisher C. H., Davignon L., Chagnon A., Skvorc-Ranko R., Belloncik S. California group virus encephalitis in three children from Quebec: clinical and serologic findings. Can Med Assoc J. 1980 Jan 12;122(1):60-2, 64. [PMC free article] [PubMed] [Google Scholar]
- Feltz E. T., List-Young B., Ritter D. G., Holden P., Noble G. R., Clark P. S. California encephalitis virus: serological evidence of human infections in Alaska. Can J Microbiol. 1972 Jun;18(6):757–762. doi: 10.1139/m72-120. [DOI] [PubMed] [Google Scholar]
- HAMMON W. M., REEVES W. C. California encephalitis virus, a newly described agent. Calif Med. 1952 Nov;77(5):303–309. [PMC free article] [PubMed] [Google Scholar]
- Henderson B. E., Coleman P. H. The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol. 1971;13:404–461. [PubMed] [Google Scholar]
- KOKERNOT R. H., McINTOSH B. M., WORTH C. B., DE MORAIST, WEINBREN M. P. Isolation of viruses from mosquitoes collected at Lumbo, Mozambique. I. Lumbo virus, a new virus isolated from Aedes (Skusea) pembaensis Theobald. Am J Trop Med Hyg. 1962 Sep;11:678–682. doi: 10.4269/ajtmh.1962.11.678. [DOI] [PubMed] [Google Scholar]
- Lindsey H. S., Calisher C. H., Mathews J. H. Serum dilution neutralization test for California group virus identification and serology. J Clin Microbiol. 1976 Dec;4(6):503–510. doi: 10.1128/jcm.4.6.503-510.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monath T. P., Nuckolls J. G., Berall, Bauer H., Chappell W. A., Coleman P. H. Studies on California encephalitis in Minnesota. Am J Epidemiol. 1970 Jul;92(1):40–50. doi: 10.1093/oxfordjournals.aje.a121178. [DOI] [PubMed] [Google Scholar]
- Parkin W. E., Hammon W. M., Sather G. E. Review of current epidemiological literature on viruses of the California arbovirus group. Am J Trop Med Hyg. 1972 Nov;21(6):964–978. doi: 10.4269/ajtmh.1972.21.964. [DOI] [PubMed] [Google Scholar]
- Wellings F. M., Sather G. E., Hammon W. M. Immunoelectrophoretic studies of the California encephalitis virus group. J Immunol. 1971 Jul;107(1):252–259. [PubMed] [Google Scholar]